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Abstract 
A first step in mastitis management is to describe the udder health situation on a farm. From 
an economic point of view, parameters such as incidence of clinical mastitis, bulk milk 10 
somatic cell count and percentage of cows with increased somatic cell count should be 
combined with an estimation of the impact of the disease on farm profitability. To estimate 
the costs of mastitis, the following cost factors should be taken into account: decreased (milk) 
production, veterinary services, diagnostics, drugs, discarded milk, labour, decreased product 
quality, increased risk of other diseases and increased risk of culling.  Reviewing existing 15 
estimates of the costs of mastitis, revealed estimates of € 28 (for only clinical mastitis) to 
more than € 97 per average cow on the farm per year. In a recent Dutch study, the costs for 
mastitis (clinical and subclinical), was estimated at € 78 per average cow present on a farm 
per year. Data from commercial Dutch dairy farms showed that these costs could differ 
largely between farms (€ 17 - € 198 per average cow on the farm per year).Farmers tended to 20 
underestimate these costs. This underlines the importance of specifying the costs of mastitis 
for individual farms instead of using generic estimations.  
The next step is the selection of management factors to reduce the level of mastitis. Based on 
scientific literature and expertise, the effect of 19 mastitis prevention measures for different 
mastitis situations has been estimated and the costs and benefits of these measures were 25 
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estimated accordingly. The net benefits of mastitis prevention measures do differ between 
farms and is not always positive. Although economic calculations to support decisions of 
dairy farmers are important, farmers’ attitude and economic behaviour should also be looked 
at. 
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Introduction 
Mastitis is a production disease and is implicitly associated with dairy production. Production 
diseases are the most expensive diseases on dairy farms. Due to the chronic nature of mastitis, 
economic damage is spread out over the year. The economic damage of the most important 35 
cost factors, such as milk production decreases and risk of culling, are not directly visible as 
costs. Thererfore, the costs of mastitis might be underestimated.  
Economic calculations are meant to support decision making, which can take place at various 
levels. In order to use economics in decision support at the herd level, the knowledge of the 
decision maker or advisor should go beyond the average costs of mastitis. 40 
The costs of mastitis have been quantified in several occasions for several countries, and at 
the 4th IDF International Mastitis Conference, a generic framework for mastitis management 
has been given (Hogeveen and Osteras, 2005). Since that conference, much new information 
on the economics of mastitis and mastitis prevention has been developed. The goal of this 
contribution is to describe the costs of mastitis and of mastitis management. The following 45 
topics will be given: a description of mastitis from an economic perspective, the most recent 
cost calculations including the variation in costs between farms, the cost-effectiveness of 
improved mastitis management and finally the economics of mastitis will be shortly discussed 
with regard to behavioural change.  
 50 
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Mastitis from an economic perspective 
A framework 
Basically, animal health economics is dedicated to support decisions. Although we often focus 
on the dairy farm when discussing mastitis, mastitis should be looked upon from a broader 55 
perspective. A good background of this perspective is given by McInerney (1996). In a 
livestock production system, resources (input) are processed on a farm into several products. 
The main product of a dairy farm is obviously milk. The dairy processing industry processes 
the raw milk and makes products that are bought by consumers. Milk and milk products are 
useless when they do not improve the welfare of the society by increasing human satisfaction. 60 
Because they give satisfaction, consumers are willing to pay a price for the dairy products. 
Diseases may affect this process in different ways (Figure 1): 
1. Lower the efficiency of the production process, leading to lower efficacy of the use of 
resources, either by a lower level of output or by a higher need of resources to 
maintain the same level of output. This is an important mechanism for mastitis and the 65 
cost estimates presented in this report are all on this pathway.The cost estimates given 
in this contribution are all on this pathway. 
2. Lower the suitability of products for processing, either by a lower quality of the 
product, or by more complicated processing of the product. Very high levels of 
somatic cell count are known to affect, for instance, the cheese yield and shelf life of 70 
dairy products (see for instance Santos et al 2003). This mechanism is, however, not 
very important in most dairy producing countries.  
3. Affect the human well-being directly, for instance through zoonotic diseases. This 
mechanism is of limited importance for mastitis, because only very few intramammary 
infections are potentially zoonotic. Antibiotic residues may be an indirect effect of 75 
effect of mastitis on human well-being. 
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4. Reduce the total value a society gains from livestock. This is an indirect economic 
effect, which may occur due to mastitis problems, when people lose trust in milk. The 
image of the dairy industry and its products is an important issue in this mechanism.   
This pathway might become more and more important for mastitis in relation to 80 
animal welfare and image of dairy production. Unfortunately, there are no data 
available on this subject.      
 
 
 85 
Figure 1. Pathways through which mastitis affects the dairy production system (adapted after 
McInerney 1996). 
 
These 4 pathways affect the dairy farmer directly through a lower production or a lower price 
for lower quality products, or indirectly through a lower demand for dairy products, which 90 
affects the price. It also implies that decisions with regard to diseases can be taken at different 
levels. Decisions can be taken at the farm level, either with regard to individual animals (do I 
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treat this animal?), the herd (do I improve the level of prevention?), the dairy processor (do 
we want our dairy farmers to improve the bulk milk somatic cell count?) or at society level 
(do we make more strict laws to prevent antibiotic resistance?). 95 
 
Effects of mastitis on farm profitability 
 
When evaluating the economic effects of mastitis, it is necessary to know the basic resource-
using process of the dairy farm (McInerney 1996). This resource-using process can be 100 
presented as a production function (Figure 2). The production function represents the 
efficiency of deriving output (milk, calves and meat) from variable resources such as 
feedstuffs and health care (input), within the constraints of the farm structure (for instance the 
available land, buildings, labour and management capacity of the farmer). This process is 
more efficient (in terms of resources needed for a certain amount of output) for a farm with a 105 
low level of mastitis (the top curve in Figure 2) than for a farm with a high level of mastitis 
(the bottom curve in Figure 2). With more mastitis, more resources are needed for the same 
amount of produced milk. The optimum level of production is given by the ratio between PR, 
the price of the resources and PQ, the price of production (milk price). If for instance, the milk 
price increases, the slope of the ratio line will become lower and the optimal level of milk 110 
production will be higher. Because of the difference in production curves, we do not have to 
think only in terms of less production (from A to B) or in more resources needed, but we have 
a different optimum (moving A to F). This means that the damage of mastitis is a combination 
of decreased output (QL – QH) and decreased input (RL – RH). In a quota situation, this 
becomes even more complex, because farmers produce a fixed amount of milk (the output is 115 
constant).  
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 120 
Figure 2. Effect of mastitis under optimal economic management.  
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• Decreased product quality 135 
• Increased risk of new cases of the same disease or of other diseases 
• Increased risk of culling 
• Materials and investments for prevention 
Although the relative cost of the factors might differ between countries and between regions, 
the economic principles behind them are the same. A more detailed description of these 140 
factors can be found elsewhere (Halasa et al 2007; Hogeveen and Østerås 2005; Petrovski et 
al 2006).  
 
Costs of mastitis  
Recent calculations 145 
A review on the costs of mastitis has recently been published by Halasa et al (2007). Those 
papers described in that review that were published between 1993 and 2006 and that 
calculated the costs of clinical mastitis, either per case or per average cow on the farm, are 
presented in Table 1. In addition to the papers reviewed by Halasa et al (2007), Table 1 also 
presents four more recent calculations. First, using a herd simulation model, the estimated 150 
avoidable losses in the Swedish situation were estimated to be € 97 per cow year (Hagnestam-
Nielen and Østergaard 2009). The maximum level of avoidable losses is assumed to be a 
situation where the risk of mastitis is 0.1 of the default risk of mastitis. Thus, the total costs of 
mastitis in that study, were more than € 100 per cow year. Secondly, a dynamic bio-economic 
simulation model was developed (Halasa et al 2009b), aiming at modelling transmission of 155 
pathogens between cows in a herd. In that study, losses due to lower milk production were 
calculated by taking the marginal costs for having additional heifers that have to be milked to 
compensate lower milk yields. Consequently, the milk production losses in that study were 
low. Thirdly, in a study of Bar et al. (2008) a dynamic programming model to optimize 
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culling in relation to mastitis was used. This potentially is a valuable approach, because 160 
culling is an important cost factor, which is very difficult to model because large differences 
exist between farmers in their approach of culling.  
 
 
 165 
Finally, a recent study of Huijps et al  (2008) describes a tool, meant for farmers and their 
advisors, to calculate farm specific costs of mastitis. For average Dutch circumstances, the 
costs of a case of clinical mastitis were estimated to be € 210, varying from € 235 for clinical 
mastitis in the first month post partum to € 164 for clinical mastitis in the last part of lactation. 
The costs for subclinical mastitis were dependent on the number of cows with an increased 170 
somatic cell count and were due to milk production losses. For a farm with an average 
production of 8,500 kg per 305 days and a bulk milk somatic cell count of 200,000 cells/ml, 
these costs were € 20 per average cow on the farm per year. Using an average incidence for 
Table 1. Overview of cost calculations for clinical mastitis, either per case of clinical 
mastitis, or per cow in the herd. 
Category Miller1 
1993 
Kossaibati2 
1997 
Huijps 
2008 
Hagnestam-
Nielsen3 2009 
Halasa 
2009b 
Bar4 
2008 
Level Cow Case  Cow Cow-year Cow Cow 
Milk production losses 12 52-70 36 78 11 -5 
Labour 3 1 4 - 11 - 
Treatment 0-4 1-12 156 - 14 - 
Culling 11 67 22 - 46 - 
Death  2 20 0 - 0 - 
Veterinarian 2 2-27 1 - 2 - 
Milk quality - - 0 - 0 - 
Materials 6 - 0 - 0 - 
Diagnostics - - 0 - 0 - 
Total 30 286 787 97 84 61 
1 Costs of treatment were calculated per pathogen. Calculations included costs for prevention 
2 Costs of mastitis were categorised as mild, severe, or fatal.In the table, however, the minimum and 
maximum costs are calculated, taking into account the prevalence of mastitis in each category.  
3 Costs were calculated as the difference between the default risk and the lowest possible risk, being 
0.1 of default risk 
4 Costs were calculated under optimized culling 
5 Unknown or not calculated 
6 Including costs for discarded milk 
7 In the original paper, the total costs of mastitis were € 140 per cow per year. The figure given here 
(€ 78 per cow/year) is derived by using recent Dutch calculations of milk production losses due to 
increased somatic cell count (Halasa et al 2009a). 
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clinical mastitis (30 cases per 100 cows per year) the total costs of mastitis for a Dutch dairy 
farm with 65 cows were calculated at € 78 per average cow on the farm per year. Costs for 175 
production losses are the largest part of these costs, as is presented in Table 2.  
 
Table 2. Costs of mastitis calculated for the average Dutch situation (Basic) and according to 
data collected on 64 Dutch dairy farms. The mean, minimum and maximum values are given. 
  Farmers data 
 Default Min Mean Max 
Input     
Farm size (nr cows) 65 28 83 160 
Farm size (kg quota) 650,000 195,000 702,621 1,500,000 
Yearly mastitis  incidence (%) 30 6 29 100 
Bulk milk somatic cell count (cells/ml) 200,000 60,000 178,484 300,000 
Costs milk production losses (€/kg) 0.12 0 7.47 12 
Costs visit of veterinarian (€/visit) 20 0 23.50 100 
Costs of drugs (€/treatment) 20 5 33.18 110 
Value of farmers labour (€/hour) 18 0 18.83 200 
Costs of culling (€/culled cow) 480 0 382.50 750 
Total costs for mastitis (€/cow present) 78 17 78 198 
 
Diffferences between farms 
As stated above, the economic consequences of disease may differ between farms. 180 
Additionally, the incidence and severity of disease may also differ. Farmer reported data on 
mastitis and farmers’ estimation of cost factors from 64 dairy farms are summarized in Table 
2. The incidence of clinical mastitis differed largely between farms, as did bulk milk somatic 
cell count and the number of cows with an increased somatic cell count. From an economic 
point of view, the variation in costs of, for instance, milk production losses, labour and culling 185 
is much more interesting than the average costs. The costs associated with a decreased milk 
production due to disease differed from 0 to € 0.12 per kg milk. Estimation of these costs 
under the Dutch quota circumstances is difficult. Based on marginal costs and benefits of 
having additional cows to fill a milk quota, the authors estimated a default value of € 0.12 per 
kg milk. This means that either the author’s estimation was too high, or that farmers 190 
underestimate the costs associated with milk production losses. Also a large variation could be 
seen in costs for culling. Finally the costs for additional labour differed largely between farms 
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(0 – 200 € per hour). In these costs for labour, some farmers did not look at opportunity costs 
per se, but took also the willingness to pay to prevent the labour associated with clinical 
mastitis into account. Under practical circumstances, the costs per cow present on a farm for 195 
mastitis varied between € 17 and € 198 (Table 2). In the same study, before calculating the 
farm specific costs of mastitis, farmers were asked to estimate the total costs of mastitis for 
their farm. Of the 64 dairy farmers, 18 (28 %) had a good or a slight overestimation of the 
costs of mastitis on their farm. In total 46 (72 %) farmers underestimated the costs of mastitis 
on their farm. The maximum difference between calculated and expected costs was € 122 per 200 
cow per year. These results emphasize the need for farm-specific calculations on the costs of 
mastitis.  
 
Cost-efficiency of management  
Effects of preventive measures 205 
Costs of mastitis, as such, are not interesting. Costs that cannot be avoided do not give much 
room for improvement. A first indication about avoidable costs is to compare the costs for 
mastitis between farms. Part of that difference can be due to structural differences between 
farms (for instance, the age of the buildings and milking equipment) or to economic valuation 
of production differences. Culling for instance, can be more expensive for one farm than for 210 
another due to differences in cost of heifer raising. In all situations, however, part of the 
differences between farms can be attributed to management. For decision support this is the 
most interesting part. We often see room for improvement, but what is the most efficient 
management measure to advise? A first step to systematically work on that is to evaluate the 
effect of different management measures on the mastitis situation of a farm.  215 
In a recent study (Huijps et al 2009b), two kinds of inputs were used to determine the efficacy 
of 18 different management measures, literature and expertise. Management measures were 
based on NMC (www.nmconline.org) and UGCN (www.ugcn.nl) recommendations. Because 
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literature was incomplete, expert opinions were additionally included. The experts were asked 
to indicate a minimum, most likely and maximum effect for every management measure, 220 
specified for a 100% environmental mastitis problem and a 100% contagious mastitis 
problem. The results of the expert sessions and the literature search were combined to 
determine the efficacy of the management measures in one overall distribution, consisting of a 
minimum, mean, and maximum value (Table 3).  
 225 
Table 3. Most likely effects (ML, with ranking between brackets) and minimum (Min) and 
maximum (Max) effects for the different management measures given as a percentage 
decrease in incidence of clinical mastitis for a 100% environmental and a 100% contagious 
situation. 
 Environmental Contagious 
Management measure ML 
(ranking) 
Min ; Max ML 
(ranking) 
Min ; Max 
Milking clinical cases last 4.75 (15) 3.11 ; 6.58 9.56 (7) 6.98 ; 12.50 
Milking subclinical cases last 2.63 (17) 1.52 ; 4.25 12.08 (5) 8.17 ; 16.58 
Separate cloth 6.08 (10) 3.21 ; 8.96 9.61 (6) 5.59 ; 13.84 
Wash dirty udders 6.68 (9) 4.50 ; 9.03 4.60 (15) 3.11 ; 5.93 
Prestripping 2.99 (16) 1.68 ; 4.35 2.94 (17) 1.61 ; 4.38 
Milkers’ gloves 0.26 (18) 1.68 ; 4.35 1.81 (18) -8.59 ; 8.66 
Post milking teat disinfection 36.51 (1) 31.97 ; 39.23 37.15 (1) 32.44 ; 40.08 
Flushing clusters clinical  5.03 (12) 1.05 ; 8.72 8.55 (9) 1.90 ; 14.25 
Flushing clusters subclinical  5.03 (12) 1.05 ; 8.72 8.55 (9) 1.90 ; 14.25 
Replace teat cup liners 6.03 (11) 3.69 ; 8.44 7.82 (11) 5.68 ; 9.68 
Treatment protocol 5.03 (12) 2.56 ; 7.81 6.02 (12) 3.53 ; 8.77 
Drying off  11.75 (5) 7.41 ; 16.28 14.02 (4) 8.94 ; 19.72 
Keep cows standing  9.47 (7) 5.94 ; 13.19 5.18 (14) 2.94 ; 7.47 
Dry cow minerals 14.98 (3) 11.19 ; 18.90 14.27 (3) 10.87 ; 17.98 
Prevent overcrowding 12.06 (4) 7.98 ; 16.25 8.75 (8) 5.59 ; 12.10 
Clean stalls 11.57 (6) 7.94 ; 15.42 5.55 (13) 3.04 ; 8.40 
Clean yards 8.17 (8) 4.84 ; 11.76 4.28 (16) 2.25 ; 6.58 
Optimize feed 17.00 (2) 12.44 ; 21.73 16.48 (2) 12.27 ; 20.82 
 
Net benefit of preventive measures 
When the effects of the management measures are known, costs of the management measures 
and benefits as the decreased costs of mastitis can be calculated. These calculations have been 
carried out for three different (theoretical) farms: the default dairy farm described before to 230 
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determine the most likely costs of mastitis, a problem farm and a good farm with respect to 
udder health (Table 4). For each management measure, the costs (including labour) to 
implement the management measure were calculated per cow per year. The net benefits of a 
management measure represent the difference between the current costs of mastitis and the 
new costs of mastitis plus the costs of the management measure. In these calculations it was 235 
assumed that the preventive measure was not carried out yet and would be carried out 
completely.  
Two preventive measures, keeping cows standing after milking (‘keep cows standing’) and 
rinsing the milk cluster after milking a cow with clinical mastitis (‘rinse clusters clinical’) had 
a positive net benefit in all three situations (Table 4). The preventive measures washing dirty 240 
udders (‘Wash dirty udders’), wearing milkers’gloves (‘wear milkers’ gloves’), and blanket 
use of dry cow antibiotics (‘drying off’) have positive net benefits for all situations except for 
the ‘good’ farm. The preventive measures using post milking teat disinfection (‘Post milking 
teat disinfection’) and supplementation of dry cow minerals (‘dry cow minerals’) vary 
between negative net benefits (for the ‘good’ farm), zero net benefits, and positive net 245 
benefits.  
In many situations the application of preventive measures is not cost effective and, from an 
economic point of view, should not be applied. However, in the calculations a stable, 
endemic, mastitis situation was assumed. The effect of a preventive measure is an 
improvement of the mastitis situation towards a new, stable, level. Additional preventive 250 
measures do also play a role in preventing sudden downturn of the mastitis situation. This can 
be regarded as a mastitis outbreak. This effect has not been taken into account. Moreover, it 
might be that estimated effect of management measures is sometimes under estimated. For 
instance, it is known from specific studies under the same economic circumstances that the 
use of blanket dry cow therapy over no dry cow therapy at all is cost-effective (Huijps et al 255 
2007).   
 
 
 
 260 
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Table 4. Characteristics of three farms (average, mastitis problem farm and good mastitis 
situation farm) and the net benefits (€/cow/year) of 18 mastitis prevention measures for 
the three types of farms. 
 Farm type 
  Average Problem Good 
Farm characteristic    
    Nr cows 65 65 65 
    Production (kg/cow/year) 8,500 8,500 8,500 
    % environmental mastitis 65 50 50 
    % contagious mastitis 35 50 50 
    BTSCC 200 350 100 
    Incidence of clinical mastitis (%) 30 40 10 
    Milking places in milking parlour 12 12 12 
   Costs of mastitis (€/farm/year) 4,743 7,199 1,405 
   Costs of mastitis (€/cow/year 73 111 22 
Net benefits (€/cow/year) of management measure 
   Milking clinical last -29,21 -38,86 -9,16 
   Milking subclinical last -27,64 -35,95 -10,03 
   Separate cloth -16,95 -11,94 -21,48 
   Wash dirty udder 2,18 5,35 -2,47 
   Prestripping -28,34 -23,35 -32,12 
   Milkers’ gloves 2,05 7,31 -2,72 
   Dipping 0,33 15,69 -21,44 
   Rinse clusters clinical 6,07 13,82 0,92 
   Rinse clusters subclinical -116,40 -169,94 -46,25 
   Replace teat cup liners -6,76 -2,98 -10,05 
   Treatment protocol -3,74 1,25 -9,12 
   Drying off 3,77 14,50 -5,39 
   Keep cows standing 3,71 9,08 0,77 
   Dry cow minerals -0,26 9,13 -8,82 
   Overcrowding -14,16 -7,21 -20,15 
   Clean boxes -47,03 -40,92 -50,81 
   Clean yards -45,04 -41,75 -50,05 
   Optimize feed -10,88 -2,82 -20,79 
 265 
 
Concluding remarks 
Economic behaviour 
Because farming is an economic activity, the economic effects of mastitis and mastitis 
management should be known to the farmers. However, farmers’ economic behaviour is not 270 
always as expected using neo-classical economic theory.  For instance, although from an 
economic point of view different types of cost factors can be regarded as exchangeable when 
they are equal in monetary terms, Dutch farmers do value different types cost factors 
differently (Huijps et al 2009a). Long term investments were considered preferable over 
changing routines.  275 
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The attitude of farmers towards mastitis is another important aspect in explaining the mastitis 
situation on a farm (Jansen et al 2009). Therefore, calculating costs does not guarantee a 
change of behaviour. For instance, in a pilot study on the value of economic information 
associated with milk production recording information, farmers thought that the cost 
calculations of high somatic cell counts specifically made for their farm, were not relevant for 280 
them (Hogeveen et al 2010). Finally, from the field of behavioural economics, it is known that 
people have a loss aversion, which indicates that losses loom larger than gains. This is also 
manifested in mastitis management. It has been shown that bulk milk somatic cell count 
penalties seem to be a higher motivation for changes in mastitis management than bonuses 
(Valeeva et al 2007). Another example is that farmers who already had implemented a 285 
specific management measure were more likely to continue doing this than farmers who 
applied a different management regime, regardless of the availability of more effective or 
lower-cost alternatives (Huijps et al 2010).  
 
What’s new? 290 
In this contribution, the costs of mastitis and the net benefits of preventive measures have 
been described. It was already known that mastitis costs money. The high costs of mastitis are 
recently confirmed by studies from Sweden, the USA and the Netherlands. Data on the 
variation of costs of mastitis are new as well as is the fact that farmers do underestimate the 
costs of mastitis largely and that it is, therefore, important to be able to calculate farm specific 295 
costs of mastitis. New is also the attempt to estimate the effects of preventive measures on the 
incidence of mastitis and the bulk milk somatic cell count. Effects of preventive measures do 
differ from farm to farm and estimation of these effects is difficult. Therefore, both costs of 
mastitis and net benefits of mastitis prevention should be calculated for each dairy farm 
specifically. These calculations should be supported by computer tools. Besides an 300 
optimisation of preventive measures at the farm level, cow level decisions, such as treatment 
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decisions can also be optimised (e.g., Steeneveld et al 2007; Steeneveld et al 2010). These are 
not worked out in this contribution. An interesting item for the future is the relation between 
mastitis, animal welfare and image of dairy production (pathway 4 in Figure 1). The possible 
effect of a change in image of milk on the demand for dairy products and consequentially, the 305 
effect on milk price should be studied. These effects might be more important for the income 
of dairy farmers than the costs of mastitis due to an inefficient production (pathway 1 in 
Figure 1) as described in this contribution. 
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